Markets:

Overview

News

Currencies

International

Treasuries

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

9.570 +2.140 (+28.80%)

Streaming Delayed Price Updated: 11:56 AM EST, Feb 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vir Biotechnology, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 02, 2021

Good morning, trader! We're gearing up for another busy day of trading with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

27 Stocks Moving in Thursday's Pre-Market Session ↗

December 02, 2021

Gainers Phunware, Inc. (NASDAQ: PHUN) rose 25.8% to $4.09 in pre-market trading after surging around 12% on Wednesday. Digital World Acquisition Corp. (NASDAQ: DWAC)...

Via Benzinga

Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant ↗

December 02, 2021

GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have announced an update to bioRxiv, a preprint server, with preclinical data for...

Via Benzinga

52 Biggest Movers From Yesterday ↗

December 01, 2021

Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 30, 2021

Gainers Cumberland (NASDAQ:CPIX) stock...

Via Benzinga

Why Did HC Wainwright Beef Up Vir Biotech's Target Price? ↗

November 30, 2021

H.C. Wainwright has raised the Vir Biotechnology Inc (NASDAQ:

Via Benzinga

Mid-Day Market Update: Barnes & Noble Education Drops Following Q2 Results; Cumberland Pharmaceuticals Shares Jump ↗

November 30, 2021

Midway through trading Tuesday, the Dow traded down 0.88% to 34,827.81 while the NASDAQ fell 0.78% to 15,659.31. The S&P also fell, dropping 0.3832% to 4,616.53. The U....

Via Benzinga

Topics Stocks

Adagio Continues Its Run As Biotech Stocks Moderna, BioNTech Dive On Omicron Threat ↗

November 30, 2021

Biotech stocks diverged Tuesday with Adagio continuing a run on the potential for its antibody to target Covid's omicron variant.

Via Investor's Business Daily

35 Stocks Moving In Tuesday's Mid-Day Session ↗

November 30, 2021

Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares jumped 105.9% to $4.53. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an...

Via Benzinga

GFAI Stock: The Thailand Deal That Has Guardforce AI Investors Saying Cha-Ching Today ↗

November 30, 2021

Guardforce AI (GFAI) stock is running higher on Tuesday thanks to news of a deal with Hadyai CCC and the Bank of Thailand.

Via InvestorPlace

Topics Artificial Intelligence

Why Vir Biotechnology Stock Is Soaring Today ↗

November 30, 2021

An analyst upped his price target for the biotech stock.

Via The Motley Fool

VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why. ↗

November 30, 2021

Vir Biotechnology has a Covid-19 treatment that its CEO says will do well against new variants. Amid uncertainty, VIR stock is climbing.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 30, 2021

Gainers Cumberland (NASDAQ:CPIX) shares rose 91.81% to $4.22 during Tuesday's pre-market session. The company's market cap stands at $62.4 million. First Wave...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 30, 2021

Good morning, investor! We're starting off Tuesday with a breakdown of the biggest pre-market stock movers you need to know about!

Via InvestorPlace

50 Biggest Movers From Yesterday ↗

November 30, 2021

Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial...

Via Benzinga

Adagio shares soar on antibody potential against new COVID variant omicron ↗

November 29, 2021

Stifel analyst Stephen Willey believes vaccines alone are unlikely to sufficiently address the COVID-19 pandemic.

Via Talk Markets

3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries ↗

November 29, 2021

The news of a new variant of the coronavirus Friday sent financial markets into a tailspin. The adversity could present an opportunity for a h...

Via Benzinga

Why Vir Biotechnology Is Up More Than 13% Today ↗

November 29, 2021

Investors are looking to capitalize on the latest curveball thrown by the coronavirus contagion.

Via The Motley Fool

33 Stocks Moving In Monday's Mid-Day Session ↗

November 29, 2021

Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares jumped 116.4% to $86.13 after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational...

Via Benzinga

Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail? ↗

November 29, 2021

Smaller companies are working on next-generation approaches to Covid treatment.

Via Investor's Business Daily

56 Biggest Movers From Friday ↗

November 29, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on...

Via Benzinga

48 Stocks Moving In Friday's Mid-Day Session ↗

November 26, 2021

Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 26, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 68.43% to $17.18 during Friday's pre-market session. The market value of their outstanding shares is at $119.6...

Via Benzinga

US Government Agrees To Purchase GSK-Vir Biotech's COVID-19 Antibody Doses Worth $1B ↗

November 17, 2021

The United States government has signed contracts worth about $1 billion to secure the antibody-based COVID-19 treatment developed by GlaxoSmithKline plc (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 17, 2021

Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The company's market cap stands at $66.5 million. The...

Via Benzinga

The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment ↗

November 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Atea Announces Termination of Strategic Collaboration With Roche Atea...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 17, 2021

Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

25 Stocks Moving in Wednesday's Pre-Market Session ↗

November 17, 2021

Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10...

Via Benzinga

GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19 ↗

November 12, 2021

GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have announced topline data from COMET-TAIL Phase 3 trial evaluating sotrovimab delivered...

Via Benzinga

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗

November 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.